Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11833155 Combination therapy for treatment of myeloproliferative neoplasms

Patent 11833155 was granted and assigned to Incyte on December, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 7 Dec, 2023
"Created via: Patent importer"
Golden AI profile picture
Golden AI
created this topic on 7 Dec, 2023
Edits made to:
Infobox (+131 properties)
Article (+358 characters)
‌

 US Patent 11833155 Combination therapy for treatment of myeloproliferative neoplasms

Article

Patent abstract

The present application relates to treatment of myeloproliferative neoplasms using the JAK1/JAK2 inhibitor, ruxolitinib, in combination with a BET protein inhibitor, 2,2,4-trimethyl-8-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)-6-(methylsulfonyl)-2H-1,4-benzoxazin-3(4H)-one, wherein the combination is unexpectedly synergistic.

Infobox
Is a
Patent
Patent
0
Patent Applicant
Incyte
Incyte
0
Current Assignee
Incyte
Incyte
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
118331550
Patent Inventor Names
Matthew Stubbs0
Phillip C. Liu0
Date of Patent
December 5, 2023
0
Patent Application Number
173370060
Date Filed
June 2, 2021
0
Patent Citations
‌
US Patent 7153845 Bioadhesive progressive hydration tablets
0
‌
US Patent 7167750 Obesity treatment with electrically induced vagal down regulation
0
‌
US Patent 7235258 Sustained-release formulations for treating CNS-mediated disorders
0
‌
US Patent 7265108 Nitrogen containing heterocyclic compounds and medicines containing the same
0
‌
US Patent 7335667 Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-4-yl-amines as Janus kinase inhibitors
0
‌
US Patent 7358255 Therapeutic agent for keratoconjunctival disorder
0
‌
US Patent 7387793 Modified release dosage forms of skeletal muscle relaxants
0
‌
US Patent 7517870 Use of compounds that interfere with the hedgehog signaling pathway for the manufacture of a medicament for preventing, inhibiting, and/or reversing ocular diseases related with ocular neovascularization
0
‌
US Patent 7544372 Modified release dosage forms of skeletal muscle relaxants
0
‌
US Patent 7598257 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
0
‌
US Patent 7683171 1
0
‌
US Patent 7745437 Compounds and compositions as protein kinase inhibitors
0
‌
US Patent 7750007 Imidazo[1,2-beta]pyridazine and pyrazolo[1,5-alpha]pyrimidine derivatives and their use as protein kinase inhibitors
0
‌
US Patent 7834022 Metabolites of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
0
‌
US Patent 8053433 Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors
0
‌
US Patent 8158616 Azetidine and cyclobutane derivatives as JAK inhibitors
0
‌
US Patent 8309718 4-pyrazolyl-N-arylpyrimidin-2-amines and 4-pyrazolyl-N-heteroarylpyrimidin-2-amines as janus kinase inhibitors
0
‌
US Patent 8410265 Processes for preparing JAK inhibitors and related intermediate compounds
0
‌
US Patent 8415362 Pyrazolyl substituted pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
0
‌
US Patent 8420629 Azetidine and cyclobutane derivatives as JAK inhibitors
0
‌
US Patent 8440679 Bicyclic compounds and their uses as dual c-SRC / JAK inhibitors
0
‌
US Patent 8445488 Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as Janus kinase inhibitors
0
‌
US Patent 8486902 Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H-pyrrolo[2,3-d] pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
0
‌
US Patent 8513270 Substituted heterocycles as Janus kinase inhibitors
0
‌
US Patent 8530485 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
0
‌
US Patent 8541425 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
0
‌
US Patent 8563541 Azepine inhibitors of Janus kinases
0
‌
US Patent 8604043 3-[4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
0
‌
US Patent 8633186 Modulation of chemosensory receptors and ligands associated therewith
0
‌
US Patent 8637529 Pyrazolo[3,4-
0
‌
US Patent 8669249 Poly (ADP-ribose) polymerase (PARP) inhibitors
0
‌
US Patent 8691807 Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors
0
‌
US Patent 8716303 N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
0
‌
US Patent 8722693 Salts of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
0
‌
US Patent 8741895 Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as Janus kinase inhibitors
0
‌
US Patent 8748401 Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
0
‌
US Patent 8765734 Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
0
‌
US Patent 8822481 Salts of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d] pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
0
‌
US Patent 8829013 Salts of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
0
‌
US Patent 8835423 Azepine inhibitors of janus kinases
0
‌
US Patent 8841318 Substituted heterocycles as janus kinase inhibitors
0
‌
US Patent 8883806 Processes for preparing JAK inhibitors and related intermediate compounds
0
‌
US Patent 8889697 Metabolites of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
0
‌
US Patent 8933085 Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors
0
‌
US Patent 8933086 Heteroaryl substituted pyrrolo[2,3-B]pyridines and pyrrolo[2,3-B]pyrimidines as Janus kinase inhibitors
0
‌
US Patent 8946245 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
0
‌
US Patent 8987442 Deuterium-substituted xanthine derivatives and methods of use
0
‌
US Patent 8987443 Processes and intermediates for making a JAK inhibitor
0
‌
US Patent 8993582 Processes for preparing JAK inhibitors and related intermediate compounds
0
‌
US Patent 9000161 Processes for preparing JAK inhibitors and related intermediate compounds
0
‌
US Patent 9012642 Pyrrolopyridinone compounds and methods for treating HIV
0
‌
US Patent 9023840 Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors
0
‌
US Patent 9034884 Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as JAK inhibitors
0
‌
US Patent 9079912 Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as Janus kinase inhibitors
0
‌
US Patent 9090611 Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors
0
‌
US Patent 9181271 Tricyclic fused thiophene derivatives as JAK inhibitors
0
‌
US Patent 9206187 Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as Janus kinase
0
‌
US Patent 9216984 3-[4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl]octane—or heptane-nitrile as JAK inhibitors
0
‌
US Patent 9221845 Processes and intermediates for making a JAK inhibitor
0
‌
US Patent 9227985 Tricyclic heterocycles as bet protein inhibitors
0
‌
US Patent 11214573 Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors
0
‌
US Patent 9290506 Processes for preparing JAK inhibitors and related intermediate compounds
0
‌
US Patent 9290514 Tricyclic heterocycles as BET protein inhibitors
0
‌
US Patent 9309246 Tricyclic heterocycles as BET protein inhibitors
0
‌
US Patent 9315501 Bicyclic heterocycles as BET protein inhibitors
0
‌
US Patent 9334274 N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
0
‌
US Patent 9359358 Cyclohexyl azetidine derivatives as JAK inhibitors
0
‌
US Patent 9376439 Salts of the janus kinase inhibitor (R)-3(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
0
‌
US Patent 9399640 Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitors
0
‌
US Patent 9464088 Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
0
‌
US Patent 9487521 Processes and intermediates for making a JAK inhibitor
0
‌
US Patent 9498467 Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1
0
‌
US Patent 9527864 Tricyclic heterocycles as BET protein inhibitors
0
‌
US Patent 9533997 Tricyclic heterocycles as BET protein inhibitors
0
‌
US Patent 9540368 1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins
0
‌
US Patent 9611269 Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors
0
‌
US Patent 9623029 3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]octane- or heptane-nitrile as JAK inhibitors
0
‌
US Patent 9624241 Tricyclic heterocycles as BET protein inhibitors
0
‌
US Patent 9655854 Sustained release dosage forms for a JAK1 inhibitor
0
‌
US Patent 9662335 Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as janus kinase inhibitors
0
‌
US Patent 9737516 Bicyclic heterocycles as bet protein inhibitors
0
‌
US Patent 9777003 Tricyclic heterocycles as bet protein inhibitors
0
‌
US Patent 9834565 Tricyclic heterocycles as bet protein inhibitors
0
‌
US Patent 9850257 Tricyclic heterocycles as BET protein inhibitors
0
‌
US Patent 9918990 Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitors
0
‌
US Patent 9938294 Tricyclic heterocycles as BET protein inhibitors
0
‌
US Patent 9957268 1H-pyrrolo[2,3,c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins
0
‌
US Patent 9957628 System for evaluation of current distribution in electrodes of electrochemical plants
0
‌
US Patent 9974790 Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as janus kinase inhibitors
0
‌
US Patent 9999619 Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
0
‌
US Patent 10166191 Sustained-release dosage forms of ruxolitinib
0
‌
US Patent 10189832 Crystalline solid forms of a BET inhibitor
0
‌
US Patent 10227359 Tricyclic heterocycles as bet protein inhibitors
0
‌
US Patent 10329305 Amorphous solid form of a BET protein inhibitor
0
‌
US Patent 10398699 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
0
‌
US Patent 10442803 Tricyclic heterocycles as bet protein inhibitors
0
‌
US Patent 10464947 Tricyclic heterocycles as BET protein inhibitors
0
‌
US Patent 10472358 1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins
0
‌
US Patent 10513522 Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors
0
‌
US Patent 10561616 Sustained release dosage forms for a JAK1 inhibitor
0
‌
US Patent 10618910 Tricyclic heterocycles as BET protein inhibitors
0
‌
US Patent 10626114 Crystalline solid forms of a BET inhibitor
0
‌
US Patent 10639310 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
0
‌
US Patent 10640506 Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidines derivatives as JAK inhibitors
0
‌
US Patent 10695337 Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
0
‌
US Patent 10766900 Baricitinib intermediate, method for forming Baricitinib intermediate, and method for preparing Baricitinib or pharmaceutically acceptable salt thereof
0
‌
US Patent 10781209 1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins
0
‌
US Patent 10858372 Amorphous solid form of a BET protein inhibitor
0
‌
US Patent 10874616 Sustained-release dosage forms of ruxolitinib
0
‌
US Patent 10919912 Tricyclic heterocycles as BET protein inhibitors
0
‌
US Patent 11045421 Sustained release dosage forms for a JAK1 inhibitor
0
‌
US Patent 11059821 1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins
0
‌
US Patent 11285140 Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
0
‌
US Patent 11331320 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
0
‌
US Patent 11337927 Sustained-release dosage forms of ruxolitinib
0
‌
US Patent 11377446 Crystalline solid forms of a BET inhibitor
0
‌
US Patent 6852727 Benzimisazo[4,5-f]isoquinolinone derivatives
0
‌
US Patent 6953776 Ophthalmic formulations
0
‌
US Patent 7005436 Heterocyclo inhibitors of potassium channel function
0
Patent Primary Examiner
‌
Paul V Ward
0
CPC Code
‌
A61K 31/538
0

Find more entities like US Patent 11833155 Combination therapy for treatment of myeloproliferative neoplasms

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo